16 /100
LOW RISK
Score updated May 29, 2026

PHAR — Pharming Group N.V. Dilution Risk Tracker

Track PHAR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PHAR — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for PHAR.
🔔 Track PHAR — Get forecast alerts →

💹 Market Data

Market Cap$964.74M
Shares Outstanding70.63M
FloatN/A
Cash$170.18M
Debt$116.20M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 139.6% shares (2025Q4 vs prior)
10 institutional holders · 139.6K shares
#1 Silverberg Bernstein Capital Management LLC 50.5K shares
#2 NewEdge Advisors, LLC 28.9K shares
#3 MILLENNIUM MANAGEMENT LLC 20.4K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest8.2K
Days to Cover1.4
% of FloatN/A
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track PHAR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PHAR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for PHAR
📊 PHAR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PHAR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.